Abstract
On analysis ofin vitro assays of human natural killer (NK) cell function the inadequacy of commonly used methods of expressing lytic activity was apparent. A comparison was made of the data obtained using modifications of two equations—the simple exponential fit and the von Krogh equations. Both of these equations were found to satisfy the following essential criteria for use in these assays. First, the majority of the results obtained in the chromium-release assay could be used in data reduction; second, the resultant “dose-response” curve was reduced to linearity; and third, a single numerical expression was obtained which was directly proportional to the cytotoxic activity. Of the two methods the more conventional exponential fit was found to be the simpler to use. The closeness of fit of the experimentally derived data to the ideal curves did not support the possibility that normal lymphocyte preparations contain suppressor cells capable of inhibiting NK activity. Data have also been presented showing that NK-sensitive targets could be categorized with respect to their susceptibility by comparing the slopes of the target cell survival curves obtained using the exponential fit equation. These observations are relevant to the accurate assessment of NK activity in patient populations and to the determination of the effects of disease and its treatment on this activity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pross HF, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VI. A brief review. Cancer Immunol Immunother 3:7585, 1977
Herberman RB, Djeu JY, Kay HD, Ortaldo JR, Riccardi C, Bonnard GD, Holden HT, Fagnani R, Santoni A, Puccetti P: Natural killer cells: Characteristics and regulation of activity. Immunol Rev 44:43–70, 1979
Baines MG, Pross HF, Millar KG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IV. The suppressive effect of normal pregnancy. Am J Obstet Gynecol 130:741–744, 1978
Pross HF, Wilberforce K, Dean D, Kennedy JC, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VIII. Characteristics of normal lymphocytes showing consistently high or low natural killer (NK) cell activity.In The Molecular Basis of Immune Cell Function, JG Kaplan (ed). Amsterdam, Elsevier/North Holland, 1979, pp 580–584
Santoli D, Trinchieri G, Zmijewski CM, Koprowski H: HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol 117:765–770, 1976
Hersey P, Edwards A, Honeyman M, McCarthy WH: Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 40:113–122, 1979
Pross HF, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against target cells. I. The effect of malignant disease. Int J Cancer 18:593–604, 1976
Takasugi M, Ramseyer A, Takasugi J: Decline of natural non-selective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res 37:413–418, 1977
De Vries JE, Cornain S, Rumke P: Cytotoxicity of non-Tvs T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells. Int J Cancer 14:427–434, 1974
Menon M, Stefani SS: Lymphocyte mediated natural cytotoxicity in neoplasia. Oncology 35:3–7, 1978
Svedmyr E, Jondal M: Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci USA 72:1622–1626, 1975
Pross HF, Gupta S, Good RA, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease. Cell Immunol 43:160–175, 1979
Koren HS, Amos DB, Buckley RH: Natural killing in immunodeficient patients. J Immunol 120:796–799, 1978
Oshimi K, Gonda N, Sumiya M, Kano S: Natural killer effects of corticosteroids on activity in systemic lupus erythematosus. Clin Exp Immunol 40:83–88, 1980
Benczur M, Petranyi GGy, Palffy Gy, Varga M, Talas M, Kotsy B, Foldes I, Hollan SR: Dysfunction of natural killer cells in multiple sclerosis: A possible pathogenetic factor. Clin Exp Immunol 39:657–662, 1980
Parrillo JE, Fauci AS: Comparison of the effector cells in human spontaneous cellular cytotoxicity and antibody-dependent cellular cytotoxicity: Differential sensitivity of effector cells toin vivo andin vitro corticosteroids. Scand J Immunol 8:99–107, 1978
Thatcher N, Swindell R, Crowther D: Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. Clin Exp Immunol 35:171–179, 1979
Einhorn S, Blomgren H, Strander H: Interferon and spontaneous cytotoxicity in man. Acta Med Scand 204:477–483, 1978
Livnat S, Seigneuret M, Storb R, Prentice RL: Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation. J Immunol 124:481–490, 1980
Lopez C, Sorell M, Kirkpatrick D, O'Reilly RJ, Ching C: Association between pre-transplant natural kill and graftversus-host disease after stem-cell transplantation. Lancet 2:1103–1107, 1979
von Krogh M: Colloidal chemistry and immunology. J Infect Dis 19:452–477, 1916
Brunner KT, Manuel J, Cerottini JC, Chapuis B: Quantitative assay of the lytic action of immune lymphoid cells on51Cr-labelled allogeneic target cellsin vitro: Inhibition by isoantibody and by drugs. Immunol 14:181–196, 1968
Thorn RM, Henney CS: Kinetic analysis of target cell destruction by effector T cells. I. Delineation of parameters related to the frequency and lytic efficiency of killer cells. J Immunol 117:2213–2219, 1976
Zeijlemaker WP, van Oers RHJ, de Goede REY, Schellekens PThA: Cytotoxic activity of human lymphocytes: Quantitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics. J Immunol 119:1507–1514, 1977
Callewaert DM, Johnson DF, Kearney J: Spontaneous cytotoxicity of cultured human cell lines mediated by normal peripheral blood lymphocytes. III. Kinetic parameters. J Immunol 121:710–717, 1978
Boyum A: Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21 (Suppl 97):77–89, 1968
Lundgren G, Zukoski CF, Moller G: Differential effects of human granulocytes and lymphocytes on human fibroblastsin vitro. Clin Exp Immunol 3:817–836, 1968
Jondal M, Pross H: Surface markers on human B and T lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer 15:596–605, 1975
Pross HF, Baines MG: Natural killer cells in tumor-bearing patients.In Natural Killer Cells, RB Herberman (ed). New York, Academic Press, 1980, in press
Perlman D, Rahman SB, Semar JB: Antibiotic control of mycoplasma in tissue culture. Appl Microbiol 15:82–85, 1967
Brooks CG, Rees RC, Leach RH: High nonspecific reactivity of normal lymphocytes against mycoplasma-infected target cells in cytotoxicity assays. Eur J Immunol 9:159–165, 1979
Lozzio CB, Lozzio BB: Cytotoxicity of a factor isolated from human spleen. J Natl Cancer Inst 50:535–538, 1973
Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270:347–349, 1977
Cuthbert D, Wood FS: Fitting Equations to Data. Wiley-Interscience, New York, 1971, Chap 9
Sokal RR, Rohlf FJ: Biometry. The Principles and Practice of Statistics in Biological Research. WH Freeman, San Francisco, 1969
Miller RG, Dunkley M: Quantitative analysis of the51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell Immunol 14:284–302, 1974
Dunkley M, Miller RG, Shortman K: A modified51Cr release assay for cytotoxic lymphocytes. J Immunol Methods 6:39–51, 1974
Kabat EA, Mayer MM: Experimental Immunochemistry, 2nd ed. Springfield, Ill., CC Thomas Press, 1967
MacLennan ICM, Campbell AC, Gale DGL: Quantitation of K cells.In In Vitro Methods in Cell-Mediated and Tumor Immunity, BR Bloom, JR David (eds). New York, Academic Press, 1976, pp 511–522
Trinchieri G, De Marchi M, Mayr W, Sari M, Ceppellini R: Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. Transplant Proc V:1631–1646, 1973
Pross HF, Luk S, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. V. The role of serum-derived heterologous membrane antigens. Int J Cancer 21:291–298, 1978
Pross HF, Jondal M: Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol 21:226–235, 1975
Nunn ME, Herberman RB: Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells. J Natl Cancer Inst 62:765–771, 1979
Clark DA, Phillips RA, Miller RG: Characterization of cells that suppress the cytotoxic activity of T lymphocytes. I. Quantitative measurement of inhibitor cells. J Immunol 116:1020–1029, 1976
Pross HF, Baines MG: Characteristics of human natural killer cells.In Natural Killer Cells, RB Herberman (ed). New York, Academic Press, 1980, in press
Oldham RK, Djeu JY, Cannon GB, Siwarski D, Heberman RB: Cryopreservation of human lymphocyte function as measured byin vitro assays. Int J Cancer 18:145–155, 1976
Herberman RB, Nunn ME, Holden HT: Statistical Analysis and selection of baseline controls in cytotoxicity assays.In In Vitro Methods in Cell-Mediated and Tumor Immunity, BR Blood, JR David (eds). New York, Academic Press, 1976, pp 481–488
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pross, H.F., Baines, M.G., Rubin, P. et al. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1, 51–63 (1981). https://doi.org/10.1007/BF00915477
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00915477